<<

SF UK GROWTH M Acc Fund Factsheet Covering the month of August 2021 Peter Michaelis & Martyn Jones

The Fund Our experienced fund management team The Fund aims to deliver capital growth Peter Michaelis and Martyn Jones have combined industry experience of more than 25 over the long term (5 years or more) using years and are part of a team of 13 investment professionals. The team joined Liontrust as the Sustainable Future investment process to part of the acquisition of Investments (ATI) in April 2017 and were invest in companies incorporated, previously running the Sustainable Future Fund range at Aviva Investors. Peter was domiciled or which conduct significant previously Head of SRI at Aviva Investors. Martyn was at Alliance Trust for five years , business in the United Kingdom (UK). This initially as a graduate trainee and then as an analyst with the Sustainable Investme nt process uses a thematic approach to team. identify the key structural growth trends that will shape the global economy of the future Performance since manager inception date (%) and the fund managers then seek to invest in well run companies whose products and 50 operations capitalise on these transformative Liontrust Sustainable Future UK Growth MSCI UK changes. 40 IA UK All Companies Key information 30

Class Launch 10.02.20 20 Date Comparator MSCI UK 10 Benchmark 1 Comparator IA UK All Companies 0 Benchmark 2 10 Fund Size^ £1167.7m Number of Holdings 49 20 Historic Yield* 0.00% 30 Active Share** 83.55% Feb 20 Aug 20 Feb 21 Aug 21 ^Fund AUM shown is in the base currency of the fund. Discrete years' performance (%)

Ratings and awards To previous quarter 12 months ending: Jun 21 Liontrust Sustainable Future UK Growth 28.9 MSCI United Kingdom Index 17.4 IA UK All Companies sector average 27.7

Quartile ranking 2

Cumulative performance (%)

1 month 3 months 6 months YTD 1 year Since inception Liontrust Sustainable Future UK Growth 5.0 9.2 15.5 17.0 35.6 22.0 MSCI United Kingdom Index 1.9 2.6 12.6 13.7 23.8 0.0 IA UK All Companies sector average 3.2 4.4 14.6 16.9 32.4 11.0 Quartile ranking 1 1 2 2 2 2 Source: Financial Express, as at 31.08.21, total return

Key risks: Past performance is not a guide to future performance. Investment in the Fund carries the risk of potential total loss of capital. Investment decisions should not be based on shortterm performance. Discrete performance data is not available for five full 12 month periods due to the launch date of the portfolio.

*Historic yield: reflects distributions declared over the past 12 months as a percentage of the midmarket unit price. It does not include any preliminary charge and investors may be subject to tax on their distributions. **The fraction of a fund invested differently to its benchmark. A 100% active share is a fund with no holdings in the benchmark, a 0% active share is a fund identical to the benchmark.

SF UK GROWTH

Sector breakdown (%) Geographic breakdown (%) Additional information Financials 28.0 United Kingdom 92.0 Minimum initial investment £50,000,000 17.8 100.0 Minimum additional investment £500,000 Information Technology 17.0 Ireland 5.0 1 February (Final) Exdividend date 1.3 0.0 1 August Industrials 11.5 Cash and Derivatives 2.9 31 March (Final) 11.5 0.0 Distribution date 30 September Consumer Discretionary 11.3 Sedol code BL1NPJ8 6.8 ISIN code GB00BL1NPJ81 Healthcare 8.7 12.3 Risk ratios Materials 6.4 12.1 Annualised over 36 months Communication Services 4.2 Alpha 9.85% 4.4 Beta 1.02 Consumer Staples 3.7 Information Ratio 1.08 19.2 Annualised over 260 weeks Utilities 2.4 Volatility 15.90% 3.6 Benchmark volatility 16.62% Fund 2.2 Where the Fund has a short track record, the ratios shown 0.0 may be based upon the historic data of the Fund as well Other 1.6 as a representative fund or the ratio may be calculated over a shorter time period. 1.4

¢ Fund ¢ MSCI UK Charges

Top 10 holdings (%) Initial charge 0.00% Unilever 3.7 Ongoing Charges Figure* 0.71% 3.4 Included within the OCF is the Annual 0.60% Management Charge** GlaxoSmithKline 3.4 *The Ongoing Charges Figure (OCF) covers all aspects of Legal & General 3.4 operating a fund during the course of its financial year. Oxford Biomedica 3.4 These include the annual charge for managing the fund, administration and independent oversight functions, such Smurfit Kappa 3.4 as trustee, depository, custod y, legal and audit fees. The OCF excludes portfolio transaction costs except for an Learning Technologies Group 3.2 entry/exit charge paid by the Fund when buying or selling 3.2 units in another fund. This will have an impact on the realisable value of the investment, particularly in the sho rt 3.1 term. **These are the annual costs of running and 3i Group 3.1 managing the Fund.

Important information This document provides information about the Liontrust Sustainable Future UK Growth Fund ('the Fund') and Liontrust Fund Partners. Liontrust Fund Partners LLP (2 Savoy Court, London WC2R 0EZ) is authorised and regulated in the UK by the Financial Conduct A uthority (FRN 518165) to undertake regulated investment business. Liontrust Fund Partners does not give financial or investment advice. This document does not constitute or form part of, and should not be construed as, an invitation to buy or sell units an d neither this document nor anything contained or referred to in it shall form the basis of, or be relied on in connection with, any offer or commitment whatsoever. The value of units and the income generated from them can fall as well as rise and are not guaranteed; investors may not get back the amount originally subscribed. Investors should not purchase the Fund referred to in this document except on the basis of information contained in the Fund's Prospectus. We recommend that investors who are not prof essional investors should contact their professional adviser. The Fund's Prospectus and Key Investor Information Document (KIID) are available from www.liontrust.co.uk or direct from Liontrust.